Swiss pharmaceutical firm Novartis has announced the completion of the spinoff of its generics and biosimilars business. Starting from Wednesday, the division will trade separately under the name Sandoz. This…
(Novartis) Roche will buy its almost one-third voting right or 53.3 million shares in rival Novartis AG for $20.7 billion. The shares, priced at $388.99 or 356.93 Swiss francs, means…
Novartis has agreed to acquire U.S. based neuroscience company Cadent for up to $770 million, according to press release. Cadent will receive $210 million upfront payment and will be eligible…